Morphic (NASDAQ:MORF) Rating Reiterated by TD Cowen
TD Cowen reaffirmed their hold rating on shares of Morphic (NASDAQ:MORF – Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. Several other brokerages have also issued reports on MORF. Royal Bank of Canada reiterated a sector perform rating and set a $57.00 price target (down from $70.00) on shares of Morphic in […]
More Stories
Western Asset Emerging Markets Debt Fund Inc. (EMD) To Go Ex-Dividend on September 23rd
Western Asset Emerging Markets Debt Fund Inc. (NYSE:EMD – Get Free Report) announced a monthly dividend on Tuesday, August 6th,...
Knowles (NYSE:KN) Updates Q3 2024 Earnings Guidance
Knowles (NYSE:KN – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Thursday morning. The...
Fidelity Disruptive Finance ETF (FDFF) To Go Ex-Dividend on September 20th
Fidelity Disruptive Finance ETF (NASDAQ:FDFF – Get Free Report) declared a quarterly dividend on Thursday, September 19th, NASDAQ reports. Shareholders...
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Expectations By $0.14 EPS
Rezolute (NASDAQ:RZLT – Get Free Report) posted its earnings results on Thursday. The company reported ($0.44) earnings per share (EPS)...
MillerKnoll (NASDAQ:MLKN) Issues FY25 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided...
Lennar (NYSE:LEN) Updates Q4 2024 Earnings Guidance
Lennar (NYSE:LEN – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Friday morning. The...